Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3849959 | American Journal of Kidney Diseases | 2011 | 10 Pages |
Abstract
Severe decreases in eGFR are associated with increased risk of long-term recurrent VTE, bleeding, and total mortality in patients with VTE. A greater frequency of serious comorbid conditions, difficulties implementing available management strategies, and suboptimal VTE prophylaxis during hospital admissions likely contributed to our findings.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Amisha M. PhD, MPH, Frederick A. MD, Darleen MS, Catherine RN, Ana MD, DrPH, Crystal PhD, Robert J. PhD,